Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TNXPTNXP
6 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in TONIX PHARMACEUTICALS HLDG C

GEODE CAPITAL MANAGEMENT, LLC holds 395,260 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $5M as of 2026-Q2. The position was increased (+26.2% shares). TNXP represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$5M

Current Shares

395,260

Total Value Change

+$3.9M

Total Shares Change

+333,223

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
395,260
+26.2%
$5M0.0%$12.76
33
2026-Q1
Increased
313,291
+15.2%
$4.3M0.0%$13.94
31
2025-Q4
Increased
271,904
+35.3%
$4.2M0.0%$15.82
35
2025-Q3
Increased
200,934
+14.7%
$4.9M0.0%$24.76
31
2025-Q2
Increased
175,212
+182.4%
$6.3M0.0%$34.89
44
2025-Q1
New
62,037
-
$1.1M0.0%$20.17
35

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used